跳至主要内容
临床试验/NCT00501085
NCT00501085已完成不适用

LAP-BAND AP Early Experience Trial (APEX)

Apollo Endosurgery, Inc.1 个研究点 分布在 1 个国家目标入组 521 人开始时间: 2007年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
521
试验地点
1
主要终点
Change in Percent Excess Weight

研究概览

简要总结

The purpose of this study is to evaluate the LAP-BAND AP System in severely obese patients.

详细描述

The primary objective of this study was to collect additional information about the safety and effectiveness of the LAP-BAND AP System in a real-life clinical setting. Effectiveness was assessed through the collection of weight loss data, as well as other secondary effectiveness measurements. Safety was assessed by the incidence and severity of adverse events (AEs) related to treatment.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is scheduled to receive the LAP-BAND AP System
  • Willingness to follow protocol requirements, including: the Informed Consent Form (ICF), Health Insurance Portability and Accountability Act (HIPAA) forms, follow-up schedule, completion of patient questionnaires.

排除标准

  • Per the LAP-BAND AP System Directions For Use (DFU)

结局指标

主要结局

Change in Percent Excess Weight

时间窗: Baseline to 5 Years

Subjects' Percent Excess Weight Loss (%EWL) from baseline over the 5 year period post LAP-BAND implantation was measured. Excess Weight = Baseline weight - Ideal weight, where ideal weight is based on a BMI of 25 kg/m2.

次要结局

  • Subject BMI From Baseline to 5 Years Post LAP-BAND Implantation(Baseline to 5 years)
  • Subject Reported Satiety(Baseline to 5 Years)
  • Subject Reported Quality of Life(Baseline to 5 Years)
  • Subject Reported Sleepiness (Epworth Sleepiness Scale)(Baseline to 5 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

LAP-BAND AP Early Experience Trial (APEX) | 临床试验